Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study 301: BLI4900 Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

ClinicalTrials.gov ID: NCT04446299

Public ClinicalTrials.gov record NCT04446299. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 5:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Safety and Efficacy Comparison of BLI4900 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare the safety and efficacy of BLI4900 bowel preparation to an FDA-approved control as 2-day, split-dose bowel preparations prior to colonoscopy in adult patients.

Study identification

NCT ID
NCT04446299
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Braintree Laboratories
Industry
Enrollment
519 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 13, 2020 (Actual)
Primary completion
Dec 22, 2020 (Actual)
Completion
Jan 22, 2021 (Actual)
Last update posted
Nov 7, 2023

2020 – 2021

United States locations

U.S. sites
25
U.S. states
16
U.S. cities
25
Facility City State ZIP Site status
301 Research Site 18 Huntsville Alabama 38501 —
301 Research Site 24 Sun City Arizona 85351 —
301 Research Site 7 San Diego California 92114 —
301 Research Site 16 Clearwater Florida 33756 —
301 Research Site 12 Jacksonville Florida 32216 —
301 Research Site 9 Palm Harbor Florida 34684 —
301 Research Site 4 Palmetto Bay Florida 33157 —
301 Research Site 26 Port Orange Florida 32127 —
301 Research Site 14 St. Petersburg Florida 33709 —
301 Research Site 25 Sunrise Florida 33351 —
301 Research Site 2 Decatur Georgia 30033 —
301 Research Site 10 Indianapolis Indiana 46202 —
301 Research Site 3 Monroe Louisiana 71201 —
301 Research Site 17 Shreveport Louisiana 71105 —
301 Research Site 11 Flowood Mississippi 39232 —
301 Research Site 13 Chesterfield Missouri 48047 —
301 Research Site 19 Reno Nevada 89511 —
301 Research Site 15 Brooklyn New York 11235 —
301 Research Site 5 Great Neck New York 11023 —
301 Research Site 23 New York New York 10033 —
301 Research Site 6 Raleigh North Carolina 27612 —
301 Research Site 21 Mentor Ohio 44060 —
301 Research Site 20 Hixson Tennessee 37434 —
301 Research Site 1 Ogden Utah 84405 —
301 Research Site 22 Milwaukee Wisconsin 53215 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04446299, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 7, 2023 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04446299 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →